STOCK TITAN

CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

CTT Pharmaceutical Holdings (OTCQB:CTTH) has received approval from OTC Markets Group for uplisting its common shares to the OTCQB Market, effective March 10, 2025. The company will continue trading under the symbol 'CTTH'.

The uplisting to OTCQB, a premier marketplace for early-stage pharmaceutical companies developing new technology, is expected to enhance trading liquidity and provide a more streamlined trading experience for U.S. shareholders. Companies listed on OTCQB must maintain current reporting status and undergo annual PCAOB audits.

The company plans to make formal announcements regarding the uplisting on March 10, 2025, followed by a CEO news release to shareholders on March 12, 2025.

Loading...
Loading translation...

Positive

  • Uplisting to OTCQB Market approved
  • Expected increase in trading liquidity
  • Enhanced visibility for U.S. investors

Negative

  • None.

News Market Reaction 1 Alert

-14.29% News Effect

On the day this news was published, CTTH declined 14.29%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.

CTT Pharma - 813-606-0060

SOURCE: CTT Pharmaceutical Holdings, Inc.



View the original press release on ACCESS Newswire

FAQ

When will CTT Pharmaceutical Holdings (CTTH) begin trading on the OTCQB Market?

CTTH will begin trading on the OTCQB Market on March 10, 2025.

What are the benefits of CTTH's uplisting to OTCQB Market?

The uplisting is expected to provide greater liquidity and a more seamless trading experience for U.S. shareholders.

What requirements must CTTH meet to maintain OTCQB listing?

CTTH must maintain current reporting status and undergo yearly PCAOB audits.

When will CTTH's CEO release news about the uplisting to shareholders?

The CEO will issue a news release to shareholders on March 12, 2025.
Ctt Pharmaceutic

OTC:CTTH

CTTH Rankings

CTTH Latest News

CTTH Stock Data

2.62M
18.80M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Ottawa